Trials / Completed
CompletedNCT01212666
The Efficacy of Adductor-Canal-Block (ACB) in Patients After Anterior Cruciate Ligament (ACL) Reconstruction
The Effect of Adductor-Canal-Block (ACB) in Patients After Anterior Cruciate Ligament (ACL) Reconstruction in Day Case Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Glostrup University Hospital, Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The Purpose of this study is to determine whether Adductor-Canal-Block is superior to placebo when it comes to analgetic efficacy after reconstruction of the anterior cruciate ligament.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ropivacain | Ultrasound-guided ACB; 30 mL Ropivacain 7,5 mg/mL. Single dose. |
| PROCEDURE | Saline | Ultrasound-guided Adductor Canal Block; 30 mL Saline. Single dose. |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2010-10-01
- Last updated
- 2012-09-11
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01212666. Inclusion in this directory is not an endorsement.